Align Technology Inc (ALGN)
271.50
-2.06
(-0.75%)
USD |
NASDAQ |
May 17, 16:00
271.43
-0.07
(-0.03%)
Pre-Market: 20:00
Align Technology Revenue (Annual): 3.862B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.862B |
| December 31, 2022 | 3.735B |
| December 31, 2021 | 3.953B |
| December 31, 2020 | 2.472B |
| December 31, 2019 | 2.407B |
| December 31, 2018 | 1.966B |
| December 31, 2017 | 1.473B |
| December 31, 2016 | 1.080B |
| December 31, 2015 | 845.49M |
| December 31, 2014 | 761.65M |
| December 31, 2013 | 660.21M |
| December 31, 2012 | 560.04M |
| December 31, 2011 | 479.74M |
| Date | Value |
|---|---|
| December 31, 2010 | 387.13M |
| December 31, 2009 | 312.33M |
| December 31, 2008 | 303.98M |
| December 31, 2007 | 284.33M |
| December 31, 2006 | 206.35M |
| December 31, 2005 | 207.12M |
| December 31, 2004 | 172.83M |
| December 31, 2003 | 122.72M |
| December 31, 2002 | 69.70M |
| December 31, 2001 | 44.81M |
| December 31, 2000 | 6.741M |
| December 31, 1999 | 0.411M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
2.407B
Minimum
2019
3.953B
Maximum
2021
3.286B
Average
3.735B
Median
2022
Revenue (Annual) Benchmarks
| Boston Scientific Corp | 14.24B |
| ResMed Inc | 4.223B |
| Edwards Lifesciences Corp | 6.005B |
| Stryker Corp | 20.50B |
| Zimmer Biomet Holdings Inc | 7.394B |